Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial

- Post-partum thromboprophylaxis is an important/understudied area
- Recruitment in post-partum thromboprophylaxis trials limits feasibility
- Post-partum low molecular weight heparin may cause important bleeding